Dr. Sridevi Juvvadi, MD
What this data tells you about Dr. Juvvadi
Dr. Sridevi Juvvadi is a hematology & oncology in Irving, TX, with 20 years in practice. Based on federal Medicare data, Dr. Juvvadi performed 31,137 Medicare services across 2,023 unique beneficiaries.
Between the years covered by Open Payments, Dr. Juvvadi received a total of $2,200 from 27 pharmaceutical and/or device companies across 53 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Juvvadi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 11,220 | $0 | $5 |
| Paclitaxel chemotherapy injection | 7,492 | $0 | $8 |
| Dexamethasone injection (steroid) | 2,172 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 1,800 | $19 | $66 |
| Blood draw (venipuncture) | 1,081 | $8 | $20 |
| Injection, granisetron hydrochloride, 100 mcg | 1,060 | $0 | $24 |
| Complete blood count (CBC) with differential | 1,044 | $8 | $36 |
| Comprehensive metabolic blood panel | 1,027 | $10 | $64 |
| Office visit, established patient (20-29 min) | 769 | $65 | $250 |
| Anti-nausea injection (Aloxi/palonosetron) | 440 | $1 | $114 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 298 | $23 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 285 | $104 | $707 |
| Ferritin level test (iron stores) | 194 | $13 | $60 |
| Iron level test | 192 | $6 | $27 |
| Iron binding capacity test | 192 | $9 | $35 |
| Injection, zoledronic acid, 1 mg | 138 | $7 | $431 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 125 | $20 | $128 |
| Drug injection, under skin or into muscle | 125 | $11 | $96 |
| Lactate dehydrogenase (enzyme) level | 109 | $6 | $31 |
| Injection, diphenhydramine hcl, up to 50 mg | 108 | $1 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 104 | $50 | $313 |
| Administration of chemotherapy into vein, each additional hour | 96 | $23 | $161 |
| Administration of additional new drug or substance into vein, 1 hour or less | 88 | $51 | $344 |
| Immunoglobulin level test | 84 | $9 | $56 |
| Microscopic examination for white blood cells with manual cell count | 78 | $4 | $22 |
| Complete blood count (CBC), automated | 78 | $6 | $34 |
| Office visit, established patient (10-19 min) | 72 | $37 | $150 |
| Injection of additional new drug or substance into vein | 68 | $12 | $108 |
| Measurement of immunoglobulin light chains | 64 | $17 | $60 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 64 | $1 | $19 |
| Unclassified drugs | 61 | $1 | $8 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 55 | $133 | $3,675 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 51 | $16 | $100 |
| Reticulated (young) platelet measurement | 49 | $35 | $143 |
| Telephone medical discussion with physician, 5-10 minutes | 44 | $42 | $143 |
| Infusion, normal saline solution , 1000 cc | 38 | $2 | $19 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 31 | $25 | $145 |
| Office visit, established patient (30-39 min) | 30 | $97 | $368 |
| Infusion into a vein for hydration, 31-60 minutes | 29 | $26 | $256 |
| New patient office visit (45-59 min) | 27 | $132 | $565 |
| Infusion into a vein for hydration, each additional hour | 23 | $10 | $75 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 16 | $1,187 | $4,802 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 16 | $91 | $657 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Payments are distributed across multiple categories with no single dominant type.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Juvvadi is a mixed practice specialist, with above-average Medicare volume (top 28% in TX), and mixed engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Juvvadi experienced with iron infusion (feraheme)?
Does Dr. Juvvadi receive payments from pharmaceutical companies?
How do Dr. Juvvadi's costs compare to other hematology & oncologys in Irving?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology